Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications.
about
The Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set.The unique C- and N-terminal sequences of Metallothionein isoform 3 mediate growth inhibition and Vectorial active transport in MCF-7 cells.Microarray expression profiling of dysregulated long non-coding RNAs in triple-negative breast cancerNovel potential serological prostate cancer biomarkers using CT100+ cancer antigen microarray platform in a multi-cultural South African cohort.LEM domain containing 1 promotes oral squamous cell carcinoma invasion and endothelial transmigration.Cancer-testis genes as candidates for immunotherapy in breast cancer.Emerging immunotherapy strategies in breast cancer.Immunotherapy for the treatment of breast cancer.New York esophageal squamous cell carcinoma-1 and cancer immunotherapy.A Comprehensive Guide to the MAGE Family of Ubiquitin Ligases.Immunohistochemical Analysis of the Expression of Breast Markers in Basal-like Breast Carcinomas Defined as Triple Negative Cancers Expressing Keratin 5.Simultaneous cytoplasmic and nuclear protein expression of melanoma antigen-A family and NY-ESO-1 cancer-testis antigens represents an independent marker for poor survival in head and neck cancer.Lack of XAGE-1b and NY-ESO-1 in metastatic lymph nodes may predict the potential survival of stage III melanoma patients.Long non-coding RNAs: implications in targeted diagnoses, prognosis, and improved therapeutic strategies in human non- and triple-negative breast cancer.
P2860
Q30978083-424E0FA4-4722-48DC-88BF-957F4A317A87Q33730545-7894BAB3-6CD5-4F7E-812F-ED48A56E3BE8Q36213198-0814196E-343E-4511-AD53-22D7078DA20DQ37046496-76FF8D95-1F79-4709-8E17-A463819BD9EAQ37061372-F9A73608-F6B2-4ED6-896A-4F782CF6806AQ38184648-A3C62D31-7B67-4A51-8538-1030A0CD2173Q38184650-AA2CAD5B-965C-48DA-9C34-6F672D5F237EQ38353772-94BFC03E-511A-49AE-9A17-09A8CF91645AQ38445350-6D03A7C4-D87E-4BFE-BD95-3C20CEEB7BBAQ39181769-8AFF910E-13C2-4804-86A3-B14CD07F43C4Q42509280-706594A1-3B71-452A-AEFA-98B9B19D53DCQ43616374-175F97FE-3F93-49E5-9571-AA87FE9AA5C2Q52800577-7DB9B67F-8EFE-44F1-B834-FC280E954A33Q55438036-FFEE25F3-E83C-4D10-B173-C3EDE7C83059
P2860
Cancer testis antigens and NY-BR-1 expression in primary breast cancer: prognostic and therapeutic implications.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Cancer testis antigens and NY- ...... and therapeutic implications.
@ast
Cancer testis antigens and NY- ...... and therapeutic implications.
@en
Cancer testis antigens and NY- ...... and therapeutic implications.
@nl
type
label
Cancer testis antigens and NY- ...... and therapeutic implications.
@ast
Cancer testis antigens and NY- ...... and therapeutic implications.
@en
Cancer testis antigens and NY- ...... and therapeutic implications.
@nl
prefLabel
Cancer testis antigens and NY- ...... and therapeutic implications.
@ast
Cancer testis antigens and NY- ...... and therapeutic implications.
@en
Cancer testis antigens and NY- ...... and therapeutic implications.
@nl
P2093
P2860
P356
P1433
P1476
Cancer testis antigens and NY- ...... and therapeutic implications.
@en
P2093
Achim Jungbluth
Axel zur Hausen
Dimitrios Balafoutas
Dominik Denschlag
Elmar Stickeler
Gerald Gitsch
Marc Hirschfeld
Markus Jaeger
Sebastian Mayer
P2860
P2888
P356
10.1186/1471-2407-13-271
P407
P577
2013-06-03T00:00:00Z
P5875
P6179
1045293900